Unternehmens-Profil
Merck KGaA is a German multinational science and technology company headquartered in Darmstadt, founded in 1668 as the world's oldest operating chemical and pharmaceutical firm. It operates through three core business sectors: Healthcare, Life Science, and Electronics, employing around 60,000 people across 66 countries. In Healthcare, it develops therapies in oncology, immunology, neurology, and general medicine, with key products like Erbitux for cancer treatment and offerings in fertility and endocrinology. The Life Science division, bolstered by acquisitions such as Millipore in 2010 and Sigma-Aldrich in 2015, provides over 300,000 products including tools for bioprocessing, lab solutions, and research services under brands like MilliporeSigma. Electronics focuses on semiconductor materials, effect pigments for automotive and cosmetics, and advanced solutions for digital technologies. Merck KGaA drives innovation with major R&D centers in Darmstadt, Boston, Tokyo, and Beijing, emphasizing sustainable progress and scientific breakthroughs to address global challenges in health, research, and technology.
Bewertungs-Kennzahlen
Allgemeine Finanzkennzahlen
Chart · 90 Tage
Letzter Kurs: 114,75 EUR· Stand 07.05.2026
News · Merck KGaA
- 2 Dividend Stocks to Double Up On Right Now
- Merck Scientists Publish Landmark Paper on Novel Method for Large-Scale Biocatalytic Synthesis of Investigational Oral PCSK9 Inhibitor, Enlicitide Decanoate
- 6 Pharma Dividend Stocks Yielding Up to 6.44% — and They've Survived Every Market Crash
- Merck Animal Health Selects Salesforce's Agentforce Life Sciences for Customer Engagement to Transform Animal Care and Enhance Support Experiences for Employees
- Merck Stock Looks Undervalued as KEYTRUDA Growth and Pipeline Offset Near-Term Headwinds